Rize Oncology Inc.
CNSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -215.00K | -370.00K | -400.90K | -265.60K | -170.20K |
| Total Depreciation and Amortization | 261.00K | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 46.70K | 3.50K | 17.60K | 18.20K | -1.90K |
| Change in Net Operating Assets | -105.70K | 69.80K | 700.00 | -112.40K | 73.10K |
| Cash from Operations | -13.10K | -296.70K | -382.70K | -359.80K | -99.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.00K | -- | -- | -- | -- |
| Cash from Investing | -150.00K | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 357.00K | -- | -- | -- | 347.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 357.00K | -- | -- | -- | 347.50K |
| Foreign Exchange rate Adjustments | 700.00 | 11.10K | 42.50K | -1.70K | -52.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | -22.90K | -- | -- | 0.00 |
| Net Change in Cash | 194.60K | -308.50K | -340.10K | -361.50K | 195.90K |